Contrarius Investment Management »

Intellia Therapeutics shares owned by Contrarius Investment Management

Quarter-by-quarter ownership of Intellia Therapeutics (NTLA) shares owned by Contrarius Investment Management from 13F filings

Historical chart of Contrarius Investment Management investment in Intellia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Intellia Therapeutics held by Contrarius Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intellia Therapeutics by Contrarius Investment Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $6.5M 214k 30.49
2023-09-30 $7.3M 232k 31.62
2023-06-30 $12M 294k 40.78